Krystal Biotech (KRYS) News Today $178.10 +0.25 (+0.14%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Segall Bryant & Hamill LLC Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Segall Bryant & Hamill LLC lifted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 352.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 157,144 shares of the company's stockNovember 20 at 6:49 AM | marketbeat.comFirst Turn Management LLC Has $12.37 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)First Turn Management LLC trimmed its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 37.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,942 shares of the company's stock after selling 41,280November 19 at 6:08 AM | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 31.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 98,285 shares of the company's stock after selling 45,580 shares during the period. VictNovember 19 at 3:57 AM | marketbeat.comBrokerages Set Krystal Biotech, Inc. (NASDAQ:KRYS) Target Price at $197.00November 15, 2024 | americanbankingnews.comPrincipal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Principal Financial Group Inc. reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 3.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 119,726 shares of the company's stock after selling 3,743November 14, 2024 | marketbeat.comKrystal Biotech to Present at Stifel 2024 Healthcare ConferenceNovember 12, 2024 | markets.businessinsider.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has earned a consensus recommendation of "Buy" from the nine analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and oneNovember 12, 2024 | marketbeat.comUS Exchange Highlights 3 Growth Stocks With Strong Insider OwnershipNovember 11, 2024 | finance.yahoo.comTimesSquare Capital Management LLC Increases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)TimesSquare Capital Management LLC boosted its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 37.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 114,222 shares of the company's stock after buying an addiNovember 11, 2024 | marketbeat.comJanney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Janney Montgomery Scott LLC raised its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 17.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 37,047 shares of the company's stock after acquiringNovember 9, 2024 | marketbeat.comChardan Capital Predicts Lower Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at Chardan Capital decreased their FY2025 EPS estimates for Krystal Biotech in a research note issued on Tuesday, November 5th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earnings ofNovember 8, 2024 | marketbeat.comKrystal Biotech Q2 EPS Forecast Increased by William BlairKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at William Blair lifted their Q2 2025 EPS estimates for Krystal Biotech in a note issued to investors on Monday, November 4th. William Blair analyst S. Corwin now anticipates that the company will earn $1.59 per share for the quarter, uNovember 7, 2024 | marketbeat.comHC Wainwright Expects Reduced Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at HC Wainwright reduced their FY2024 earnings per share (EPS) estimates for Krystal Biotech in a research note issued to investors on Monday, November 4th. HC Wainwright analyst J. Pantginis now anticipates that the cNovember 7, 2024 | marketbeat.comHC Wainwright Boosts Earnings Estimates for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Stock analysts at HC Wainwright upped their FY2026 earnings per share (EPS) estimates for Krystal Biotech in a research report issued on Monday, November 4th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn $7.02 perNovember 6, 2024 | marketbeat.comKrystal Biotech to Present at Guggenheim Securities Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comKrystal Biotech FY2024 EPS Forecast Lifted by William BlairKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Investment analysts at William Blair raised their FY2024 earnings estimates for Krystal Biotech in a research report issued on Monday, November 4th. William Blair analyst S. Corwin now expects that the company will earn $2.96 per share for the yNovember 6, 2024 | marketbeat.comQ3 2024 Krystal Biotech Inc Earnings CallNovember 5, 2024 | finance.yahoo.comBuy Recommendation for Krystal Biotech: Strong Financial Performance and Strategic PositioningNovember 5, 2024 | markets.businessinsider.comKrystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 5, 2024 | markets.businessinsider.comKrystal Biotech Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 5, 2024 | finance.yahoo.comKrystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at CitigroupCitigroup lifted their target price on shares of Krystal Biotech from $204.00 to $206.00 and gave the stock a "neutral" rating in a report on Tuesday.November 5, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $221.00 price objective on shares of Krystal Biotech in a report on Tuesday.November 5, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Announces Earnings Results, Beats Expectations By $0.07 EPSKrystal Biotech (NASDAQ:KRYS - Get Free Report) announced its earnings results on Monday. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.84 by $0.07. The firm had revenue of $83.84 million for the quarter, compared to the consensus estimate of $82.94 million. Krystal Biotech had a return on equity of 1.99% and a net margin of 63.73%. The business's quarterly revenue was up 879.9% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.67) EPS.November 5, 2024 | marketbeat.comKrystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory HurdlesNovember 5, 2024 | tipranks.comKrystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | seekingalpha.comKrystal Biotech (NASDAQ:KRYS) Shares Gap Down - Here's WhyKrystal Biotech (NASDAQ:KRYS) Shares Gap Down - Time to Sell?November 4, 2024 | marketbeat.comEarnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 ResultsNovember 3, 2024 | finance.yahoo.comKrystal Biotech (NASDAQ:KRYS) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comAre Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?November 1, 2024 | msn.comKrystal Biotech (KRYS) Scheduled to Post Earnings on MondayKrystal Biotech (NASDAQ:KRYS) will be releasing earnings before the market opens on Monday, November 4, Zacks reports.October 29, 2024 | marketbeat.comKrystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024October 28, 2024 | globenewswire.comHennion & Walsh Asset Management Inc. Has $2.53 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Hennion & Walsh Asset Management Inc. lowered its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 35.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,910 shares of the company's stock afterOctober 25, 2024 | marketbeat.comEverence Capital Management Inc. Invests $557,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)Everence Capital Management Inc. bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,060 shares of the company's stock, valued at aOctober 22, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of "Buy" from BrokeragesKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been given a consensus rating of "Buy" by the nine ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation aOctober 18, 2024 | marketbeat.comState Street Corp's Strategic Acquisition in Krystal Biotech IncOctober 17, 2024 | finance.yahoo.comKrystal Biotech: Q4 Catalysts Expected With VYJUVEK Revenue Growth Pressing OnOctober 14, 2024 | seekingalpha.comShaker Investments LLC OH Takes $532,000 Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Shaker Investments LLC OH purchased a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,920 shares of the company's stock, valued at approximatelyOctober 13, 2024 | marketbeat.com$100 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much TodayOctober 11, 2024 | benzinga.comBank of Montreal Can Takes $540,000 Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Bank of Montreal Can acquired a new position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,936 shares of the company's stock, valued at approxOctober 9, 2024 | marketbeat.comVera Therapeutics (VERA) Gets a Buy from TD CowenOctober 7, 2024 | markets.businessinsider.comHandelsbanken Fonder AB Sells 11,800 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Handelsbanken Fonder AB decreased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 11.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,700 shares of the company's stoOctober 7, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Takes $555,000 Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Teachers Retirement System of The State of Kentucky bought a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 3,021 shares of the company's stock, valued at approximatelyOctober 6, 2024 | marketbeat.comStifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)October 1, 2024 | markets.businessinsider.comSei Investments Co. Increases Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Sei Investments Co. boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 18.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,115 shares of the company's stock after acquiring an addSeptember 30, 2024 | marketbeat.comDriehaus Capital Management LLC Acquires 8,547 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Driehaus Capital Management LLC lifted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 7.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 118,746 shares of the company's stock after purchasing an additiSeptember 29, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Stock, Short Interest ReportSeptember 28, 2024 | benzinga.comAmalgamated Bank Acquires 6,847 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Amalgamated Bank lifted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 937.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,577 shares of the company's stock after buying an additional 6,847 shares during theSeptember 27, 2024 | marketbeat.com$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much TodaySeptember 25, 2024 | benzinga.comPraxis Precision Medicines (PRAX) Receives a Buy from TD CowenSeptember 24, 2024 | markets.businessinsider.comPublic Sector Pension Investment Board Makes New $10.04 Million Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)Public Sector Pension Investment Board purchased a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 54,656 shares of the company's stoSeptember 24, 2024 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼1.360.45▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼45▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCRX News TSHA News ALEC News PRQR News ITOS News INBX News VXRT News PASG News TEVA News BGNE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
